Futura Medical Past Earnings Performance

Past criteria checks 0/6

Key information

6.2%

Earnings growth rate

22.5%

EPS growth rate

Pharmaceuticals Industry Growth14.1%
Revenue growth rate95.4%
Return on equity-118.9%
Net Margin-210.0%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Apr 17
We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Jan 05
Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

Jul 28
Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

Mar 18
We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Sep 25
We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

Jan 10
We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

What We Learned About Futura Medical's (LON:FUM) CEO Compensation

Dec 21
What We Learned About Futura Medical's (LON:FUM) CEO Compensation

Revenue & Expenses Breakdown
Beta

How Futura Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

AIM:FUM Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233-772
30 Sep 232-653
30 Jun 232-543
31 Mar 231-534
31 Dec 220-634
30 Sep 220-634
30 Jun 220-624
31 Mar 220-524
31 Dec 210-524
30 Sep 210-423
30 Jun 210-312
31 Mar 210-312
31 Dec 200-212
30 Sep 200-414
30 Jun 200-616
31 Mar 200-718
31 Dec 190-9110
30 Sep 190-9110
30 Jun 190-819
31 Mar 190-718
31 Dec 180-616
30 Sep 180-515
30 Jun 180-414
31 Mar 180-414
31 Dec 170-414
30 Sep 170-414
30 Jun 170-313
31 Mar 170-413
31 Dec 160-414
30 Sep 160-414
30 Jun 160-514
31 Mar 160-514
31 Dec 150-515
30 Sep 150-514
30 Jun 150-414
31 Mar 150-413
31 Dec 140-312
30 Sep 140-312
30 Jun 140-312
31 Mar 140-212
31 Dec 130-212
30 Sep 130-212
30 Jun 130-212

Quality Earnings: FUM is currently unprofitable.

Growing Profit Margin: FUM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FUM is unprofitable, but has reduced losses over the past 5 years at a rate of 6.2% per year.

Accelerating Growth: Unable to compare FUM's earnings growth over the past year to its 5-year average as it is currently unprofitable


Return on Equity


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.